W Van Hul
Overview
Explore the profile of W Van Hul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
3815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Beckers S, de Freitas F, Zegers D, Mertens I, Verrijken A, Van Camp J, et al.
Endocrine
. 2012 Jul;
43(1):120-6.
PMID: 22767440
AdipoR1 is one of the adiponectin receptors which are important for adiponectin signaling. Because adiponectin is a candidate gene for common obesity, it is also hypothesized that variations in AdipoR1...
12.
Van Camp J, Beckers S, Zegers D, Verrijken A, Van Gaal L, Van Hul W
Mol Genet Metab
. 2011 Dec;
105(3):489-93.
PMID: 22189080
The Wnt pathway has been shown to play an important role in maintenance of stem cells and cell fate decisions in embryonic and adult stem cell populations. Activation of the...
13.
Perdu B, Lakeman P, Mortier G, Koenig R, Lachmeijer A, Van Hul W
Clin Genet
. 2010 Oct;
80(4):383-8.
PMID: 20950377
Osteopathia striata with cranial sclerosis (OMIM ##300373) is an X-linked dominant sclerosing bone dysplasia that presents in females with macrocephaly, cleft palate, mild learning disabilities, sclerosis of the long bones...
14.
Frost M, Nielsen T, Wraae K, Hagen C, Piters E, Beckers S, et al.
Eur J Endocrinol
. 2010 Jul;
163(3):407-12.
PMID: 20587580
Objective: Both animal and human studies have associated the endocannabinoid system with obesity and markers of metabolic dysfunction. Blockade of the cannabinoid receptor 1 (CB1) caused weight loss and reduction...
15.
Van Bezooijen R, Bronckers A, Gortzak R, Hogendoorn P, Van Der Wee-Pals L, Balemans W, et al.
J Dent Res
. 2009 Jul;
88(6):569-74.
PMID: 19587164
Sclerostin is an inhibitor of bone formation expressed by osteocytes. We hypothesized that sclerostin is expressed by cells of the same origin and also embedded within mineralized matrices. In this...
16.
Perdu B, Odgren P, Van Wesenbeeck L, Jennes K, Mackay C, Van Hul W
Calcif Tissue Int
. 2009 Mar;
84(5):355-60.
PMID: 19259722
Osteopetrosis is a disease characterised by a generalized skeletal sclerosis resulting from a reduced osteoclast-mediated bone resorption. Several spontaneous mutations lead to osteopetrotic phenotypes in animals. Moutier et al. (1974)...
17.
Brixen K, Beckers S, Peeters A, Piters E, Balemans W, Nielsen T, et al.
Calcif Tissue Int
. 2007 Dec;
81(6):421-9.
PMID: 18058054
Purpose: To investigate the impact of the Ala1330Val (rs3736228, exon 18) and Val667Met (rs4988321, exon 9) polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene on peak bone mass...
18.
Balemans W, Van Hul W
J Musculoskelet Neuronal Interact
. 2006 Dec;
6(4):355-6.
PMID: 17185822
No abstract available.
19.
Beyens G, Wuyts W, Cleiren E, de Freitas F, Tiegs R, Van Hul W
Calcif Tissue Int
. 2006 Nov;
79(5):281-8.
PMID: 17120186
Paget's disease of bone (PDB) is a common late-onset bone disorder characterized by focal areas of abnormal bone remodeling. Positional cloning efforts resulted in the identification of seven genetic loci...
20.
Verdyck P, Blaumeiser B, Holder-Espinasse M, Van Hul W, Wuyts W
Clin Genet
. 2006 Feb;
69(1):86-92.
PMID: 16451141
We present a Belgian Adams-Oliver syndrome (AOS) family with 10 affected individuals over four generations, of which six were available for this study. Clinical symptoms observed in these patients were...